genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Genetic Disease Testing
Multiomics Approach Improves Diagnosis of Rare Disease, Methylmalonic Aciduria
Base Editing
Zinc Finger Design AI Tool Opens Door to Large-Scale Gene Therapies
Cancer
Multidrug Nanoparticle Platform Improves Drug Delivery against Cancer
Cancer
Cancer’s Capacity to Resist Treatment Thwarted
Animal Models
Microbiome and its Metabolites Promote Endometriosis in Animal Model
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Artificial Intelligence
Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block
Antibodies
Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis
Bioprocessing
Cell and Gene Therapy Scale-Up Challenges
Bioprocessing
Making Molecules Instead of Growing Them
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
RNA
RNAi
Page 3
RNAi
Antisense
Gene Silencing
lncRNA
miRNA
mRNA
RNAi
shRNA
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
RNAi
RNA Interference Regulates Intestinal Function
Genome Editing
Gene Therapy Pioneers Share Genome Editing Insights at Chardan Conference
RNAi
Atalanta Therapeutics’ Branched RNAi Hunts Down Neurodegenerative Diseases
RNAi
StockWatch: Alnylam Basks in the Glow of Heart Drug’s Phase III Success
RNAi
From R&D to M&A: Novo Nordisk to Acquire Dicerna for $3.3B
RNAi
Unlike CRISPR Knockout and RNAi Knockdown, Trim-Away Depletes Proteins Straightaway
RNAi
Boehringer Ingelheim, Dicerna Launch Liver Disease Collaboration
RNAi
Alnylam, Sanofi RNAi Candidate Patisiran Aces Phase III Trial
RNAi
NEWS: Whole Genome CRISPR Screening Gets Leg Up from Newly Developed...
RNAi
“Fossil” Antiviral System May Furnish Bones of New RNA-Based Therapies
RNAi
Better Targeting, Delivery of RNAi Therapies
RNAi
MicroRNA Maneuvers Limit Time on Target, Maintain Ace Status
RNAi
CRISPR Screen IDs Human Host Genes for HIV
RNAi
Humans Rely on RNAi to Fight the Flu
RNAi
RNAi-Chemo Tag Team Slams Ovarian Cancer
1
2
3
4
...
13
Page 3 of 13
Scroll Up
Login
Subscribe
